New ingestible sensor for non-intrusive sleep disorder monitoring developed by MIT and collaborators

A recent Device study reported the effectiveness of an ingestible vitals-monitoring pill (VM pill) to monitor vital signs, including heart and respiratory rate based on a human trial.

‘Imitation is best form of flattery’: Regeneron CEO comments on Amgen’s Eylea biosimilar

Regeneron might be ready for competition with its blockbuster drug Eylea, but it’s not clear that investors are. On Thursday morning, the biotech’s leadership fielded

November 1, 2024

Abivax Publishes 2025 Financial Calendar – Biotech Investments

EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax Publishes 2025 Financial Calendar 28.01.2025 / 08:30 CET/CEST The issuer is solely responsible for the content of this

January 29, 2025

NorthStar and Convergent expand deal for prostate cancer drug

Convergent’s CONV01-α is being developed as a new treatment for prostate cancer. Credit: NMK-Studio/Shutterstock. NorthStar Medical Radioisotopes and Convergent Therapeutics have announced an expanded strategic

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.